<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cheney Research &#187; Subscribers Categories</title>
	<atom:link href="http://www.cheneyresearch.com/category/subscribers/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cheneyresearch.com</link>
	<description></description>
	<lastBuildDate>Mon, 26 Apr 2010 21:00:31 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Can structured or certain natural waters be of benefit to CFS</title>
		<link>http://www.cheneyresearch.com/2010/04/can-structured-or-certain-natural-waters-be-of-benefit-to-cfs</link>
		<comments>http://www.cheneyresearch.com/2010/04/can-structured-or-certain-natural-waters-be-of-benefit-to-cfs#comments</comments>
		<pubDate>Mon, 26 Apr 2010 02:41:56 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[redox]]></category>
		<category><![CDATA[Structured water]]></category>
		<category><![CDATA[XMRV]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=625</guid>
		<description><![CDATA[The issue of redox shifting as well as redox buffering in CFS appears of paramount importance.  Cellular energy is critically dependent on redox and reduced energy fluctuations are dependent on proper redox buffering.  In addition, many important viruses linked to CFS including herpes group viruses and the newly discovered retrovirus XMRV are likely very sensitive to the redox set point.  At optimal redox set points, no viral replication is possible.  These two concepts of viral activation and cellular energy as redox dependent makes attention to redox shifting of critical importance in CFS.  It appears that certain types of water may be very useful in adjusting the redox state of CFS in a positive direction.]]></description>
			<content:encoded><![CDATA[<p>The issue of redox shifting as well as redox buffering in CFS appears of paramount importance.  Cellular energy is critically dependent on redox and reduced energy fluctuations are dependent on proper redox buffering.  In addition, many important viruses linked to </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/04/can-structured-or-certain-natural-waters-be-of-benefit-to-cfs/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CFS venous blood gas (VBG) response to stem cells</title>
		<link>http://www.cheneyresearch.com/2010/04/cfs-venous-blood-gas-vbg-response-to-stem-cells</link>
		<comments>http://www.cheneyresearch.com/2010/04/cfs-venous-blood-gas-vbg-response-to-stem-cells#comments</comments>
		<pubDate>Mon, 26 Apr 2010 02:12:25 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Stem Cell Therapy]]></category>
		<category><![CDATA[skin turgor in CFS]]></category>
		<category><![CDATA[stem cell therapy]]></category>
		<category><![CDATA[Venous blood gases in CFS]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=623</guid>
		<description><![CDATA[This post examines dramatic changes seen in venous blood gases (VBG's) following stem cell therapy in CFS which coincides clinically with improved skin turgor occurring with the first stem cell transfusion and continuing over time.  Notable is the observation of improved skin turgor and "looking younger" which we get from many family members on observing the post-stem cell CFS cases.  What is clear clinically is that they are having better microcirculation and you can see it in their faces.]]></description>
			<content:encoded><![CDATA[<p>I am currently examining emerging venous blood gas (VBG) data, pre vs. post stem cell therapy.  A typical specific example of this data is as follows:  This is a 62 year old female with typical CFS treated with stem cells including intrathecal </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/04/cfs-venous-blood-gas-vbg-response-to-stem-cells/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Summary of stem cell therapeutic results through April 2010</title>
		<link>http://www.cheneyresearch.com/2010/04/summary-of-stem-cell-therapeutic-results-through-april-2010</link>
		<comments>http://www.cheneyresearch.com/2010/04/summary-of-stem-cell-therapeutic-results-through-april-2010#comments</comments>
		<pubDate>Mon, 26 Apr 2010 01:21:07 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Stem Cell Therapy]]></category>
		<category><![CDATA[KPS]]></category>
		<category><![CDATA[stem cell therapy]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=619</guid>
		<description><![CDATA[We are now close to 20 CFS patients who have received stem cell transfusions primarily in Panama at SCI and coming up on 8 with 12-18 months of follow-up in June.  We have three functional cures (KPS of 75-80) both clinically and by ETM, all under 36 years of age (N=3). A KPS of 75 means they can work full time with accommodation and 80 means they can work full time without accommodation in their job of choice.  All three started at KPS's of 50(2) to 60(1).  Two of these functional cures have been sick for almost 20 years, one for 8 years, two are male and one is female.  By summer, I hope to be in a position to publish the overall results at one year of follow-up. The early effects following stem cell transfusions are not that impressive functionally until about three to six months out, earlier for those under 40 and later for those over 40.  All, however, show significant......]]></description>
			<content:encoded><![CDATA[<p>We are now close to 20 CFS patients who have received stem cell transfusions primarily in Panama at SCI and coming up on 8 with 12-18 months of follow-up in June.  We have three functional cures (KPS of 75-80) both </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/04/summary-of-stem-cell-therapeutic-results-through-april-2010/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are Antioxidants Problematic in the Treatment of Chronic Fatigue Syndrome?</title>
		<link>http://www.cheneyresearch.com/2010/02/are-antioxidants-problematic-in-the-treatment-of-chronic-fatigue-syndrome</link>
		<comments>http://www.cheneyresearch.com/2010/02/are-antioxidants-problematic-in-the-treatment-of-chronic-fatigue-syndrome#comments</comments>
		<pubDate>Mon, 08 Feb 2010 03:03:20 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[New Thinking]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[Antioxidants]]></category>
		<category><![CDATA[Fish Oil]]></category>
		<category><![CDATA[Olive Oil]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=571</guid>
		<description><![CDATA[What may be a driving force for both clinical benefits as well as relative risk of using antioxidants as well as omega-3 fish oil is the redox stability of the patient being treated.  In the case of CFS, that redox stability or redox buffer capacity is very poor and demonstrable by ETM in all cases of CFS so far tested.  The point is that antioxidants are all potentially pro-oxidants and possibly harmful if used to excess in an overly oxidizing state such as CFS as they cannot be maintained in their reduced state.  If fully oxidized, antioxidants are pro-oxidants if they cannot be re-reduced.  Published meta-analysis studies of anti-oxidant use show both increased mortality and morbidity in populations of both healthy and non-healthy patients.  It is likely that if those studies could separate the redox stable vs. the redox unstable sub-sets of patients under study, the data might be much more compelling concerning the risk vs. benefit of pharmacologic  doses of antioxidants.]]></description>
			<content:encoded><![CDATA[<p>I have turned up some interesting research on large scale therapy on populations with age-related macular degeneration or AMD and antioxidant therapies in general that supports my concerns about many antioxidants observed on ETM in CFS patients. <br style=&#8221;padding: 0pt; margin: </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/02/are-antioxidants-problematic-in-the-treatment-of-chronic-fatigue-syndrome/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Results of stem cell therapy at 7 months in a family of three.</title>
		<link>http://www.cheneyresearch.com/2010/01/results-of-stem-cell-therapy-at-7-months-in-a-family-of-three</link>
		<comments>http://www.cheneyresearch.com/2010/01/results-of-stem-cell-therapy-at-7-months-in-a-family-of-three#comments</comments>
		<pubDate>Sun, 24 Jan 2010 04:06:23 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Stem Cell Therapy]]></category>
		<category><![CDATA[stem cell therapy]]></category>
		<category><![CDATA[XMRV]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=527</guid>
		<description><![CDATA[Three family members, mother, son and daughter, all with CFS, were evaluated recently in my clinic.  They all became sick in Prague, the Czech Republic, on the mothers sabbatical LOA from her college teaching position after all had a chicken-pox like illness.  They are all seven months out from stem cell therapy in Panama.  They all have improved significantly following stem cell therapy with the daughter claiming a complete cure after 17 years of illness at the age of 29.  She is the second stem cell patient claiming a complete cure and includes an unrelated 23 year old male patient, also 7 months out from stem cells.  Both cures took at least 90 days to become manifest with the first thirty days exhibiting significant hypersomnolence and with little energy to do much and typical for all the CFS stem cell patients (N=13). ]]></description>
			<content:encoded><![CDATA[<p>Three family members, mother, son and daughter, all with CFS, were evaluated recently in my clinic.  They all became sick in Prague, the Czech Republic, on the mothers sabbatical LOA from her college teaching position after all had a chicken-pox like </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/01/results-of-stem-cell-therapy-at-7-months-in-a-family-of-three/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low birth weight, diastolic heart failure and CFS &#8211; Is there a connection?</title>
		<link>http://www.cheneyresearch.com/2010/01/low-birth-weight-diastolic-heart-failure-and-cfs-is-there-a-connection</link>
		<comments>http://www.cheneyresearch.com/2010/01/low-birth-weight-diastolic-heart-failure-and-cfs-is-there-a-connection#comments</comments>
		<pubDate>Sun, 24 Jan 2010 01:28:17 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[New Thinking]]></category>
		<category><![CDATA[Diastolic Dysfunction]]></category>
		<category><![CDATA[diastolic heart failure]]></category>
		<category><![CDATA[low birth weight]]></category>
		<category><![CDATA[orthostatic intolerance]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=525</guid>
		<description><![CDATA[Two published studies show that diastolic heart failure (DHF) in the elderly and low birth weights at term in infants have occurred during the same time frame from 1990-2000.  No one has an explanation for these anomalies at the ends of the age spectrum in humans but suspect an environmental factor or factors.  We have a rising case load of diastolic dysfunction seen in 97% of our CFS cases (ave. age 49) and some appear to have what I would call compensated diastolic heart failure.  I would define compensated DHF in CFS as an extremely low cardiac output with a cardiac index (CI) below 2.0 and very poor functional capacity combined with the inability to stand which is the corollary in DHF to the inability to lay down flat in systolic heart failure (SHF).  Heart failure patients are typically below 2.0 in CI.  I have several CFS patients below that number and they cannot stand still for more than 15-30 seconds without having to sit down or fall down.  Walking or moving helps which makes sense as that would increase filling pressures and equivalent to laying down.  They might be diagnosed as having orthostatic intolerance by others.  These patients are also typically thin or near ideal body weight and have a high catabolic to anabolic ratio on 24 hour urine hormone analysis when I have measured it. ]]></description>
			<content:encoded><![CDATA[<p>A recently (18 Jan 2010) published study in the Journal of Obstetrics and Gynocology (http://visitbulgaria.info/12425-low-birth-weight-babies-born-between-1990-and-2005) indicates that for the first time since WW-II, we are seeing a decline in birth weights at term of 2 ounces in US infants in the </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2010/01/low-birth-weight-diastolic-heart-failure-and-cfs-is-there-a-connection/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More on Vitamin D3 and CFS</title>
		<link>http://www.cheneyresearch.com/2009/12/more-on-vitamin-d3-and-cfs</link>
		<comments>http://www.cheneyresearch.com/2009/12/more-on-vitamin-d3-and-cfs#comments</comments>
		<pubDate>Thu, 24 Dec 2009 01:24:41 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Hormones in CFS]]></category>
		<category><![CDATA[azoles]]></category>
		<category><![CDATA[Calcium]]></category>
		<category><![CDATA[NADPH]]></category>
		<category><![CDATA[NF Kappa B]]></category>
		<category><![CDATA[P450]]></category>
		<category><![CDATA[Vitamin D3]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=512</guid>
		<description><![CDATA[Vitamin D3 is regulated by P450 enzyme systems that are in turn decoupled due to low NADPH levels in CFS.  This raises important questions regarding the reasons that may underlie low D3 levels typical for most CFS cases.  The finding of increased intracellular calcium by UK investigators may also play into the reasons for finding low D3 in CFS.  Given these deeper issues that may underlie D3 levels suggests that aggressive D3 therapy may not be the best course of action in CFS.  D3 is a highly regulated pro-hormone and there could be good reasons for it to be down-regulated in CFS.]]></description>
			<content:encoded><![CDATA[<p>The effect of vitamin D3 on the echocardiograph ETM in CFS, but not in controls, shows a transient and negative IVRT backflash.  I would not call this effect an &#8220;oxygen toxic effect&#8221; but rather a negative redox shift caused </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/12/more-on-vitamin-d3-and-cfs/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccination &#8211; a complex decision with increasingly no good answer</title>
		<link>http://www.cheneyresearch.com/2009/12/vaccination-a-complex-decision-with-increasingly-no-good-answer</link>
		<comments>http://www.cheneyresearch.com/2009/12/vaccination-a-complex-decision-with-increasingly-no-good-answer#comments</comments>
		<pubDate>Wed, 23 Dec 2009 22:12:43 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[New Thinking]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[XMRV]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=510</guid>
		<description><![CDATA[It appears vaccine contamination risk will be a rising threat as we approach over 50 different vaccinations now recommended in children and now including the increased microbial contamination risk of cell associated vaccine manufacturing.  In such vaccination decisions, one has to weigh the risk to benefit ratio of each vaccination including the multi-vaccine vaccinations in a particular individual at one moment in time.  The longer view risk to the population of such aggressive vaccination programs is even murkier.]]></description>
			<content:encoded><![CDATA[<p>Below is a link to a patent filled on detecting contamination of vaccines with a variety of infectious diseases.  It appears contamination risk will be a rising threat as we approach over 50 different vaccinations now recommended in children. </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/12/vaccination-a-complex-decision-with-increasingly-no-good-answer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Curcumin &#8211; an herb for all seasons</title>
		<link>http://www.cheneyresearch.com/2009/12/curcumin-an-herb-for-all-seasons</link>
		<comments>http://www.cheneyresearch.com/2009/12/curcumin-an-herb-for-all-seasons#comments</comments>
		<pubDate>Wed, 23 Dec 2009 21:54:05 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Diet]]></category>
		<category><![CDATA[BDNF]]></category>
		<category><![CDATA[Curcumin]]></category>
		<category><![CDATA[MAOI]]></category>
		<category><![CDATA[NF Kappa B]]></category>
		<category><![CDATA[P450]]></category>
		<category><![CDATA[turmeric]]></category>
		<category><![CDATA[XMRV]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=508</guid>
		<description><![CDATA[Curcumin is a member of a class of complex biochemicals known as curcuminoids and the principal constituent of the spice known as turmeric and responsible for its yellow color.  In turn, turmeric is the principal spice in common yellow curry powder which can contain many spices that vary widely among popular cuisines.  Curcumin contains polyphenols that have significant medicinal properties and used historically in southeastern Asia and India and commonly  used in Ayurvedic medicine.  Turmeric is a perennial herb and member of the ginger family and native to tropical southeast Asia.  Heavy curcumin use in India is thought to explain, in part, the low incidence of Alzheimers disease as it is anti-inflammatory and an antioxidant and promotes neurogenesis.  It is also anti-bacterial and anti-viral as well as having anti-cancer properties and heavy metal chelation properties, especially iron.]]></description>
			<content:encoded><![CDATA[<p>Curcumin is a member of a class of complex biochemicals known as curcuminoids and the principal constituent of the spice known as turmeric and responsible for its yellow color.  In turn, turmeric is the principal spice in common yellow </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/12/curcumin-an-herb-for-all-seasons/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Artemisins as therapy in CFS</title>
		<link>http://www.cheneyresearch.com/2009/11/artemisins-as-therapy-in-cfs</link>
		<comments>http://www.cheneyresearch.com/2009/11/artemisins-as-therapy-in-cfs#comments</comments>
		<pubDate>Fri, 20 Nov 2009 17:01:22 +0000</pubDate>
		<dc:creator>pcheney</dc:creator>
				<category><![CDATA[Treatment]]></category>
		<category><![CDATA[artesunate]]></category>
		<category><![CDATA[herpes virus]]></category>
		<category><![CDATA[NF Kappa B]]></category>
		<category><![CDATA[oxygen narcosis]]></category>
		<category><![CDATA[Oxygen Toxicity]]></category>
		<category><![CDATA[Wormwood]]></category>
		<category><![CDATA[XMRV]]></category>

		<guid isPermaLink="false">http://www.cheneyresearch.com/?p=497</guid>
		<description><![CDATA[Before we learned that Artesunate might inhibit XMRV via NF Kappa B inhibition in August of 2009, we were aware that Artesunate was a known inhibitor of all known human herpes viruses against which it has been tested as well as HIV.  I was first introduced to Artesunate by a prominent Autism expert at a medical conference who finds it helpful in Autism.  We were also impressed that Artesunate and its relative Wormwood, using SL administration on the echo table, produced the most powerful ablation of oxygen toxicity as well as the ablation of other echo terrain map (ETM) backflashes than any other therapy we have ever used.  Both Artesunate and Wormwood will do this in 30 seconds.]]></description>
			<content:encoded><![CDATA[<p>Before we learned that Artesunate might inhibit XMRV via NF Kappa B inhibition in August of 2009, we were aware that Artesunate was a known inhibitor of all known human herpes viruses against which it has been tested as well </p>
]]></content:encoded>
			<wfw:commentRss>http://www.cheneyresearch.com/2009/11/artemisins-as-therapy-in-cfs/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
